Breaks Categories: News

TuesdayAug 27, 2019 10:47 am

CannabisNewsBreaks – CWCBExpo Heading to Los Angeles September 26 to 28, 2019

Leading Edge Expositions, a company specializing in B2B trade show production, today announced further details for the upcoming Cannabis World Congress & Business Exposition (“CWCBExpo”). The event is slated to take pace in Los Angeles, California and will run from September 26 – 28, 2019, at the Los Angeles Convention Center. A number of high-powered sponsors are supporting the expo, including its diamond sponsor, Freed, a prominent CBD company known for promoting healthy living. Marcum LLP, an accounting group; Zuber Lawler, a global law firm; and CCELL, known for its disruptive vaping technology are among other top sponsors. The conference…

Continue Reading

TuesdayAug 27, 2019 10:07 am

CannabisNewsBreaks – TransCanna Holdings Inc.’s (CSE: TCAN) (FSE: TH8) Warrants Commence Trading on the CSE

TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced that 4,207,083 common share purchase warrants began trading on the Canadian Securities Exchange (“CSE”) under the symbol ‘TCAN.WT’ as the market opened today. The warrants, each of which entitle the holder to purchase one common share of the company, were issued in accordance with a private placement financing that closed in April 2019. The warrants will expire on April 4, 2022. To view the full press release, visit http://cnw.fm/Tdm7O About TransCanna Holdings Inc. TransCanna Holdings is a Canadian-based company providing branding, transportation and distribution services, through its wholly owned California subsidiaries,…

Continue Reading

TuesdayAug 27, 2019 9:54 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Conditions

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its receipt of a new patent granted in Australia: #2016367037 / Grant Date August 15, 2019 - “Stable ready-to-drink beverage compositions comprising lipophilic active agents.” According to the update, this increases Lexaria’s portfolio to 16 awarded patents protecting its DehydraTECH(TM) drug delivery platform, with eight in the USA and eight in Australia. The new Australian patent, together with Australian Patent #2016367036 announced on August 15, 2019, are the first granted in Lexaria’s second and third patent families that differ from the company’s original…

Continue Reading

TuesdayAug 27, 2019 9:24 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Posts Q1 Fiscal 2020 Financial Results, Provides Corporate Update

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning reported financial results for the first quarter ended June 30, 2019. Among other highlights, the company reported an operating income of $2.7 million for the quarter which it primarily attributes to royalty, interest and lease income. Canopy Rivers took advantage of new invest opportunities during the quarter, providing $18.8 million to new investments in Biolumic, Zeakal and High Beauty in addition to contributing a total of $6 million to existing investees Greenhouse Juice Company and Agripharm. “In Q1 2020, we made several exciting investments in plant sciences and cannabis brands, two areas…

Continue Reading

MondayAug 26, 2019 10:43 am

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Headset Launches Cannabis Market Intelligence Tool in Canada

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, Headset, Inc., has launched its competitive cannabis market intelligence tool in Canada. Headset Insights is already trusted by hundreds of operators in numerous U.S. markets and provides users with real-time market data to help uncover strategic opportunities, monitor consumer trends and behaviors, and keep tabs on competitors. "This announcement from Headset is a testament to the company's rapid growth since being backed by RIV and joining our ecosystem in January 2019," Canopy Rivers President and CEO Narbe Alexandrian said in the news release. "We believe that…

Continue Reading

ThursdayAug 22, 2019 10:41 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Commercial Launch of ChrgD+

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the commercial launch of ChrgD+, the industry’s most advanced water-soluble multi-spectrum hemp oil in a powdered format and empowered with DehydraTECH(TM) for fast, effective delivery. ChrgD+ is available online, now for sale to US consumers at ChrgD.life. Lexaria’s technology delivers patented processes within every ChrgD+ serving to improve the consumer experience of hemp oil with CBD. ChrgD+ is formulated with the highest quality multi-spectrum hemp oil ingredients and does NOT use CBD isolates that deprive consumers of the synergistic benefits of multi-spectrum oils. In…

Continue Reading

ThursdayAug 22, 2019 9:42 am

CannabisNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Announces Receipt of SEC Comment Letter on its Form S-1 Registration Statement

California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), this morning announced its August 21, 2019 receipt of the initial comment letter from the SEC Division of Corporation Finance. According to the update, the letter requires the company to file audited predecessor financial statements for Grapefruit Boulevard Investments, Inc. and audited pro forma financial information giving effect to the reverse acquisition. “We are pleased to receive this prompt and manageable response from the SEC Staff and look forward to responding as promptly as possible and to timely provide the public with all relevant disclosure concerning Grapefruit,” Grapefruit…

Continue Reading

WednesdayAug 21, 2019 9:19 am

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Posts Letter to Shareholders

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, this morning issued a letter to shareholders discussing the company’s recent activities in line with NABIF’s goal to become a leading cannabis asset manager. “As Nabis continues to expand its footprint in the United States, we believe that now is an ideal time to update shareholders on the recent investments and acquisitions the company has made in establishing a trusted, national brand capable of sustaining long-term growth,” Nabis Holdings CEO & Director Shay Shnet stated…

Continue Reading

TuesdayAug 20, 2019 9:49 am

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Appoints Cannabis Industry Veteran as New Independent Director

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the appointment of cannabis industry veteran Emmanuel Paul to its board of directors, effective August 16, 2019. Per the update, Paul is co-founder and currently serves as CEO of IndusCann Research, a business focused on the research and commercialization of medical cannabis in India. Most recently, he was the founding partner of Spartan Wellness Corporation, a veteran-focused health care service provider that specialized in prescribing medical cannabis and providing education and ongoing care.…

Continue Reading

TuesdayAug 20, 2019 9:19 am

CannabisNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) to Commence Trading on the Toronto Stock Exchange on August 22

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto Stock Exchange (“TSX”). The company’s common shares will start trading on the TSX when the market opens on Thursday, August 22, 2019, under the symbol ‘OGI’. In order to ensure continuous trading for the company’s shareholders during the uplisting, Organigram’s shares will be delisted from the TSX Venture Exchange (“TSX.V”) at the beginning of trading on the TSX. To view the full press release, visit…

Continue Reading